GSK3B and Alzheimer disease: Additionally, GSK3β, a key regulator in AD pathology, is hyperactivated, contributing to amyloid accumulation, tau hyperphosphorylation, neuroinflammation, and synaptic dysfunction, including impaired LTP [62].